|
2024
|
Invention
|
Ido/tdo inhibitor.
A compound of formula (I) given below or a pharmaceutically acceptable salt o... |
|
2022
|
Invention
|
Conjugates binding phosphatidylserine and toll-like receptors. Presented herein, in certain aspec... |
|
|
Invention
|
Phosphatidylserine-binding conjugates. Presented herein, in certain aspects, are conjugates capab... |
|
2018
|
Invention
|
Ido/tdo inhibitor. 6 represents, for example, a substituted or unsubstituted aryl group].
|
|
|
Invention
|
Ido/tdo inhibitor. Provided is a compound represented by formula (I) or a pharmaceutically accept... |
|
2016
|
Invention
|
Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting a... |
|
2015
|
Invention
|
Nrf2-based cancer treatment and detection methods and uses.
Disclosed herein, inter alia, are me... |
|
|
Invention
|
Nrf2-based cancer treatment and detection methods and uses. Disclosed herein, inter alia, are met... |
|
2014
|
Invention
|
Peptides and peptidomimetics in combination uses and treatments for cancer patient subpopulations... |
|
2010
|
Invention
|
Compounds with anti-cancer activity. Novel substituted azole diones are provided that kill cells,... |
|
2009
|
Invention
|
Peptide compound and use thereof.
The present invention provides a method for the prophylaxis or... |
|
2008
|
Invention
|
Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity... |
|
|
Invention
|
Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid ... |
|
|
Invention
|
Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment anti-cancer ac... |
|
|
Invention
|
Compounds that abrogate dna damage induced cell cycle g2 checkpoint and/or augment anti-cancer ac... |
|
|
Invention
|
Azole dione compounds with anti-cancer activity. Novel substituted azole diones are provide... |
|
2004
|
Invention
|
Sensitivity test to predict efficacy of anti-cancer therapies. The present disclosure provides me... |
|
|
Invention
|
Anti-fungal peptidomimetics.
The invention relates to compounds including peptides and... |
|
|
Invention
|
Anti-fungal peptidomimetics. The invention relates to compounds including peptides and peptidomim... |
|
|
Invention
|
Anti-fungal compounds and methods of use. The invention relates to compounds including peptides a... |
|
2003
|
Invention
|
Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment the anti-cance... |
|
2000
|
Invention
|
Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damagin... |
